Skip to content

Enhancing PAP Adherence Among Spanish-speaking Hispanic Adults With OSA

Enhancing Positive Airway Pressure (PAP) Adherence Among Spanish-Speaking Hispanic Adults With Obstructive Sleep Apnea (OSA)

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05618444
Enrollment
50
Registered
2022-11-16
Start date
2026-09-01
Completion date
2027-04-01
Last updated
2026-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Sleep Apnea

Keywords

positive airway pressure (PAP), adherence, Hispanic, tele-management

Brief summary

This study seeks to enhance long-term positive airway pressure (PAP) adherence among Spanish-speaking Hispanic adults, a group with known PAP outcomes disparities. This study will assess the feasibility of a linguistically and culturally adapted tele-management intervention (Automated Management, AM) for Spanish-speaking Hispanic adults with OSA.

Detailed description

This feasibility study seeks to enhance long-term positive airway pressure (PAP) adherence among Spanish-speaking Hispanic adults, a group with known PAP outcomes disparities. This study will assess the feasibility, usability and effectiveness of a linguistically and culturally adapted tele-management intervention (Automated Management, AM) for Spanish-speaking Hispanic adults with obstructive sleep apnea (OSA) (N=50). A prospective, randomized, parallel group, unblinded, feasibility trial is proposed. AM is a tele-management strategy that includes evidence-based components for improving shorter-term PAP adherence consisting of education, support and troubleshooting, and brief targeted motivational enhancement delivered by tele-messaging. The automated, interactive communication is algorithmic based on PAP use and behavioral profiles defined at baseline. The innovative, technology-based intervention is designed to ensure access to sustained care that overcomes barriers such as distance/geography, transportation limitations or lost work/productivity time. As such, AM can provide equitable access to quality PAP management that may mitigate known PAP adherence disparities for minority adults with OSA. If effective for PAP adherence, these strategies may alter OSA care paradigms, improve outcomes and associated healthcare costs, and reduce disparities.

Interventions

BEHAVIORALAutomated Management (AM)

A tele-management intervention that will deliver text messages to participants via a bot - a computer program that simulates human outreach activity. Programmed messages will address evidence based intervention components for positive airway pressure (PAP) adherence, including PAP use awareness (tele-monitoring), support and troubleshooting, education, and brief motivational messaging.

Sponsors

Geisinger Clinic
Lead SponsorOTHER
American Academy of Sleep Medicine
CollaboratorOTHER
University of Pennsylvania
CollaboratorOTHER
University of Kansas
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Spanish-speaking and reading * Self-identified Hispanic * Adults ≥ 18 years-old * Males and females * Moderate-severe OSA defined as AHI ≥15 events/hour using a hypopnea criterion of a 4% oxygen desaturation (AHI4%) * Expected availability for the duration of the study (6 months from date of randomization) * Ownership of smartphone with unlimited text messaging capability * Referred to PAP treatment and able and willing to be treated with PAP

Exclusion criteria

* Other sleep apnea or nocturnal respiratory insufficiency or failure diagnosis other than OSA established by polysomnogram (PSG) or home sleep apnea test (HSAT) * Requirement of supplemental oxygen or other non-invasive ventilation modality * Women referred to PAP because of new-onset OSA with pregnancy as PAP treatment may be time-limited (enrolled women who become pregnant during the trial and are already on PAP treatment will not be excluded) * Anticipated or scheduled bariatric surgery and/or referred to sleep evaluation by bariatric surgery

Design outcomes

Primary

MeasureTime frameDescription
Patient Satisfaction6 monthsSatisfaction with quality of care and the components of care (e.g., feedback, frequency, duration), relevance of the care to the individual and their needs, and overall satisfaction with care. Assessed with the Client Satisfaction Questionnaire (CSQ-8). The CSQ-8 scores range from 8 to 32, with higher values indicating higher satisfaction.
Acceptability6 monthsDefined as the perception that a given treatment is agreeable, palatable, or satisfactory. Assessed with the Acceptability of Intervention Measure (AIM; 4 items, Likert, 1-5, where 1 = "completely disagree" and 5 = "completely agree"). Higher scores indicate higher acceptability.
Appropriateness6 monthsDefined as the perceived fit, relevance, or compatibility of a given treatment. Assessed with the Intervention Appropriateness Measure (IAM; 4 items, Likert, 1-5, where 1 = "completely disagree" and 5 = "completely agree"). Higher scores indicate higher appropriateness.

Secondary

MeasureTime frameDescription
Recruitment Rate6 monthsRecruitment Rate computed at the end of the trial
Retention Rate6 monthsRetention Rate computed at the end of the trial

Countries

United States

Contacts

CONTACTAlexa Watach, PhD, RN
awatach@nursing.upenn.edu570-271-8663
PRINCIPAL_INVESTIGATORAlexa Watach, PhD, RN

Unniversity of Pennsylvania

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 29, 2026